Recent studies have shown that the administration of an FGF21 analog to humans with obesity significantly lowered body weight and decreased LDL cholesterol and triglycerides while increasing HDL cholesterol [33]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.